Arginine is a critical substrate for the pathogenesis of Pseudomonas aeruginosa in burn wound infections

mBio

Volumn 8, Issue 2, 2017, Pages

  Everett, Jake ^a   Turner, Keith ^b,c   Cai, Qiuxian ^b   Gordon, Vernita ^b   Whiteley, Marvin ^b   Rumbaugh, Kendra ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c MONSANTO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; INTERLEUKIN 1; INTERLEUKIN 6; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR; ANTIINFECTIVE AGENT;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BURN INFECTION; CD4+ CD25+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVIRONMENTAL FACTOR; ENZYME SPECIFICITY; IMMUNOREGULATION; MICROFLUIDICS; MODULATION; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; REGULATORY T LYMPHOCYTE; ANIMAL; BURN; COMPLICATION; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PSEUDOMONAS INFECTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRULENCE; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ARGININE; BURNS; DISEASE MODELS, ANIMAL; MICE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRULENCE; WOUND INFECTION;

EID: 85019107450     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02160-16     Document Type: Article

References (45)

1. Azzopardi EA, Azzopardi SM, Boyce DE, Dickson WA. 2011. Emerging Gram-negative infections in burn wounds. J Burn Care Res 32:570-576. https://doi.org/10.1097/BCR.0b013e31822ac7e6.
2. Ansermino M, Hemsley C. 2004. Intensive care management and control of infection. BMJ 329:220-223. https://doi.org/10.1136/bmj.329.7459.220.
3. Mason AD, Jr, Mc Manus AT, Pruitt BA, Jr. 1986. Association of burn mortality and bacteremia. A 25-year review. Arch Surg 121:1027-1031. https://doi.org/10.1001/archsurg.1986.01400090057009.
4. Young LS. 1990. Gram-negative sepsis, p 611-636. In Mandell GL, Douglas RG, Jr, Bennet JE (ed), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York, NY.
5. Lyczak JB, Cannon CL, Pier GB. 2000. Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist. Microbes Infect 2:1051-1060. https://doi.org/10.1016/S1286-4579(00)01259-4.
6. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. 2009. Emerging infections in burns. Surg Infect (Larchmt) 10: 389-397. https://doi.org/10.1089/sur.2009.024.
7. Church D, Elsayed S, Reid O, Winston B, Lindsay R. 2006. Burn wound infections. Clin Microbiol Rev 19:403-434. https://doi.org/10.1128/CMR.19.2.403-434.2006.
8. Bone RC. 1996. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680-687. https://doi.org/10.7326/0003-4819-125-8-199610150-00009.
9. Gosain A, Gamelli RL. 2005. A primer in cytokines. J Burn Care Rehab 26:7-12. https://doi.org/10.1097/01.BCR.0000150214.72984.44.
10. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. 1989. Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci U S A 86:3803-3807. https://doi.org/10.1073/pnas.86.10.3803.
11. Oswald IP, Wynn TA, Sher A, James SL. 1992. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci U S A 89: 8676-8680. https://doi.org/10.1073/pnas.89.18.8676.
12. Weber J, Mc Manus A, Nursing Committee of the International Society for Burn Injuries. 2004. Infection control in burn patients. Burns 30:A16-A24. https://doi.org/10.1016/j.burns.2004.08.003.
13. Mac Conmara MP, Maung AA, Fujimi S, Mc Kenna AM, Delisle A, Lapchak PH, Rogers S, Lederer JA, Mannick JA. 2006. Increased CD4_ CD25_ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 244:514-523. https://doi.org/10.1097/01.sla.0000239031.06906.1f.
14. Ni Choileain N, Mac Conmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. 2006. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 176:225-236. https://doi.org/10.4049/ jimmunol.176.1.225.
15. Adib-Conquy M, Cavaillon JM. 2009. Compensatory anti-inflammatory response syndrome. Thromb Haemost 101:36-47. https://doi.org/10.1160/TH08-07-0421.
16. Kobayashi M, Yoshida T, Takeuchi D, Jones VC, Shigematsu K, Herndon DN, Suzuki F. 2008. Gr-1(+)CD11b(+) cells as an accelerator of sepsis stemming from Pseudomonas aeruginosa wound infection in thermally injured mice. J Leukoc Biol 83:1354-1362. https://doi.org/10.1189/jlb.0807541.
17. Bronte V, Zanovello P. 2005. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5:641-654. https://doi.org/10.1038/nri1668.
18. Rodriguez PC, Quiceno DG, Ochoa AC. 2007. L-Arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109:1568-1573. https://doi.org/10.1182/blood-2006-06-031856.
19. Xing D, Liu L, Marti GP, Zhang X, Reinblatt M, Milner SM, Harmon JW. 2011. Hypoxia and hypoxia-inducible factor in the burn wound. Wound Repair Regen 19:205-213. https://doi.org/10.1111/j.1524-475X.2010.00656.x.
20. Bernier SP, Ha DG, Khan W, Merritt JH, O’Toole GA. 2011. Modulation of Pseudomonas aeruginosa surface-associated group behaviors by individual amino acids through c-di-GMP signaling. Res Microbiol 162: 680-688. https://doi.org/10.1016/j.resmic.2011.04.014.
21. Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187:5267-5277. https://doi.org/10.1128/JB.187.15.5267-5277.2005.
22. Vander Wauven C, Piérard A, Kley-Raymann M, Haas D. 1984. Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: Evidence for a four-gene cluster encoding the arginine deiminase pathway. J Bacteriol 160:928-934.
23. Lüthi E, Baur H, Gamper M, Brunner F, Villeval D, Mercenier A, Haas D. 1990. The arc operon for anaerobic arginine catabolism in Pseudomonas aeruginosa contains an additional gene, arc D, encoding a membrane protein. Gene 87:37-43. https://doi.org/10.1016/0378-1119(90)90493-B.
24. Sato H, Okinaga K, Saito H. 1988. Role of pili in the pathogenesis of Pseudomonas aeruginosa burn infection. Microbiol Immunol 32: 131-139. https://doi.org/10.1111/j.1348-0421.1988.tb01372.x.
25. Drake D, Montie TC. 1988. Flagella, motility and invasive virulence of Pseudomonas aeruginosa. J Gen Microbiol 134:43-52. https://doi.org/10.1099/00221287-134-1-43.
26. Gosselink MP, Darby M, Zimmerman DD, Gruss HJ, Schouten WR. 2005. Treatment of chronic anal fissure by application of L-arginine gel: A phase II study in 15 patients. Dis Colon Rectum 48:832-837. https://doi.org/10.1007/s10350-004-0858-7.
27. Cassone Faldetta M, Laurenti O, Desideri G, Bravi MC, De Luca O, Marinucci MC, De Mattia G, Ferri C. 2002. L-Arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in type II diabetic patients. Diabetologia 45:1120-1127. https://doi.org/10.1007/s00125-002-0854-1.
28. Si G, Yang W, Bi S, Luo C, Ouyang Q. 2012. A parallel diffusion-based microfluidic device for bacterial chemotaxis analysis. Lab Chip 12: 1389-1394. https://doi.org/10.1039/c2lc21219f.
29. Nikata T, Sumida K, Kato J, Ohtake H. 1992. Rapid method for analyzing bacterial behavioral responses to chemical stimuli. Appl Environ Microbiol 58:2250-2254.
30. Moulton RC, Montie TC. 1979. Chemotaxis by Pseudomonas aeruginosa. J Bacteriol 137:274-280.
31. Zandifar A, Seifabadi S, Zandifar E, Beheshti SS, Aslani A, Javanmard SH. 2015. Comparison of the effect of topical versus systemic L-arginine on wound healing in acute incisional diabetic rat model. J Res Med Sci 20:233-238.
32. Murakami K, Enkhbaatar P, Yu YM, Traber LD, Cox RA, Hawkins HK, Tompkins RG, Herndon D, Traber DL. 2007. L-Arginine attenuates acute lung injury after smoke inhalation and burn injury in sheep. Shock 28:477-483. https://doi.org/10.1097/shk.0b013e31804a59bd.
33. Yan H, Peng X, Huang Y, Zhao M, Li F, Wang P. 2007. Effects of early enteral arginine supplementation on resuscitation of severe burn patients. Burns 33:179-184. https://doi.org/10.1016/j.burns.2006.06.012.
34. Marin VB, Rodriguez-Osiac L, Schlessinger L, Villegas J, Lopez M, Castillo-Duran C. 2006. Controlled study of enteral arginine supplementation in burned children: Impact on immunologic and metabolic status. Nutrition 22:705-712. https://doi.org/10.1016/j.nut.2006.03.009.
35. Ali S, Roberts PR. 2006. Nutrients with immune-modulating effects: What role should they play in the intensive care unit? Curr Opin Anaesthesiol 19:132-139. https://doi.org/10.1097/01.aco.0000192800.95172.47.
36. Appleton J. 2002. Arginine: Clinical potential of a semi-essential amino acid. Altern Med Rev 7:512-522.
37. + myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res 11:6713-6721. https://doi.org/10.1158/1078-0432.CCR-05-0883.
38. Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, Martin F, Apetoh L, Rébé C, Ghiringhelli F. 2010. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res 70: 3052-3061. https://doi.org/10.1158/0008-5472.CAN-09-3690.
39. Holloway BW, Krishnapillai V, Morgan AF. 1979. Chromosomal genetics of Pseudomonas. Microbiol Rev 43:73-102.
40. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298. https://doi.org/10.1126/science.280.5361.295.
41. O’Toole GA, Kolter R. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295-304. https://doi.org/10.1046/j.1365-2958.1998.01062.x.
42. Stieritz DD, Holder IA. 1975. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: Description of a burned mouse model. J Infect Dis 131:688-691. https://doi.org/10.1093/infdis/ 131.6.688.
43. Rumbaugh KP, Griswold JA, Hamood AN. 1999. Contribution of the regulatory gene las R to the pathogenesis of Pseudomonas aeruginosa infection of burned mice. J Burn Care Rehab 20:42-49. https://doi.org/ 10.1097/00004630-199901001-00008.
44. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Griswold JA, Auer M, Hamood AN, Rumbaugh KP. 2007. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 75:3715-3721. https://doi.org/10.1128/IAI.00586-07.
45. Déziel E, Comeau Y, Villemur R. 2001. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J Bacteriol 183:1195-1204. https:// doi.org/10.1128/JB.183.4.1195-1204.2001.